Skip to main content
Figure 2 | Journal of Translational Medicine

Figure 2

From: De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer

Figure 2

PCR-determined levels of miR-375 and miR-122 are associated with clinical outcome. Levels of miR-375 and miR-122 were measured by PCR and normalized to the level of miR-16 in each sample. Comparisons were carried out between the two groups of relapsed vs. non-relapsed (A) or pCR vs. non-pCR (B). For each group, mean and the standard error of the mean (SEM) are indicated. T-tests were performed between the two groups and P values are indicated.

Back to article page